Thanks to all who met with us during #DCATWeek! We enjoyed connecting with so many of you throughout the week. We look forward to continuing conversations and strengthening partnerships to pursue a more resilient tomorrow, today. We are grateful to DCAT (Drug, Chemical & Associated Technologies Association) for hosting a great event this week.
关于我们
Resilience (National Resilience, Inc.) is a first-of-its-kind manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.
- 网站
-
https://www.resilience.com
Resilience的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- San Diego,CA
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Biomanufacturing、Gene Therapy、Cell Therapy、Vaccines、Biologics和Nucleic Acids
地点
Resilience员工
动态
-
Resilience is proud to sponsor the #DCAT 2025 Women’s Networking Breakfast. We had the privilege to hear from global change-maker and Founder of Copia Komal Ahmad, who shared her journey and vision to transform the world one innovative solution at a time. Stories like hers inspire us to pursue our mission to drive innovative biomanufacturing. Thanks DCAT (Drug, Chemical & Associated Technologies Association) & the other sponsors for a great morning!
-
-
Interested in exploring our Center of Excellence for fill/finish and device assembly and packaging in Cincinnati, Ohio? Now you can take a virtual tour of our Cincinnati facility right from your office! Discover our FDA-licensed site, featuring high-speed fill lines for vials, cartridges, and pre-filled syringes (PFS), with exciting new line expansions set for 2025. Plus, we're growing our device assembly and packaging suites. Discover an impressive site with a proud legacy of delivering commercial medicines across the globe. Take a tour today: https://hubs.ly/Q03bQTnG0
-
-
Good morning, New York City! Our team is touching down today for #DCATWeek 2025. We look forward to meeting with innovators looking to positively impact the biopharmaceutical manufacturing value chain. Seeking a manufacturing partner who can meet your drug substance or drug product demands? Book a meeting with our team: https://hubs.ly/Q039Zj910
-
Every moment reduced in vein-to-vein time gives your autologous CAR-T cell therapy a better chance to do precisely what you designed it to do. Leveraging the Short Cycle CAR-T Manufacturing technology from Resilience, you can cut your manufacturing time down to just 3 days – all while capitalizing on the potency and persistence of both naive and central memory T cells. Wondering how this compares to conventional CAR-T manufacturing methods? Read our latest White Paper today: https://hubs.ly/Q03bQV6s0 #CellTherapy
-
There’s no template that demonstrates the step-by-step route of getting your product to the market, and we understand that process can be daunting. But you’re not alone. We’re here to support the growth of your program from a small sprout, all the way to market. Together, we can identify the building blocks – the framework, scale-up, and manufacturing – you need for success. Take our innovative drug substance questionnaire to discover which steps in your drug substance manufacturing process might be most effectively accomplished through a partnership, and receive a custom list of resources to help guide you through the process: https://hubs.ly/Q0361-4w0
-
-
Uncover critical quality attributes (CQAs) that correlate with clinical outcomes for your CAR-T cell therapy with unmatched precision. Kona Multiomics Characterization Assay Services uses multi-modal data combining mRNA and surface protein markers from the same single cells. Access accurate and reliable data generated by a state-of-the-art assay. Download the Kona fact sheet here and see the data: https://hubs.ly/Q037q_H10
-
Just one week to go until #DCATWeek 2025! Are you eager to connect with a dependable manufacturing partner who can fulfill your clinical and commercial biomanufacturing needs with available capacity? Maximize your time in New York City by scheduling a meeting with Evan Pasenello, Head of Commercial Services, and the Resilience team. Book your meeting today! https://hubs.ly/Q039ZkjR0
-
Happy International Women's Day! Today, and every day, we celebrate the incredible achievements, resilience, and contributions of women around the world. This year’s theme is #AccelerateAction, a worldwide call to acknowledge that with the right action and support, positive progress can be made for women everywhere. We want to take a moment to recognize the impact that women make here at Resilience in all aspects of our work, from research and development to production and quality control, and digital innovation.?On this #IWD2025, let's continue to uplift, support, and amplify the voices of women everywhere, and recommit ourselves to creating a more equitable future for all.
-
-
Putting down roots with a CDMO partner is a big decision, and we want to ensure you can do it with confidence. Your product has its own unique growth curve, and determining if our manufacturing capacity and expertise is the right fit, is essential. We invite you to take our innovative questionnaire to discover which of our services might align with your drug product scale-up needs. At the end, you’ll receive a customized list of resources to help guide you through to your next phase. Learn more today: https://hubs.ly/Q03613rg0
-